| UniProt ID | FAH2A_HUMAN | |
|---|---|---|
| UniProt AC | Q96GK7 | |
| Protein Name | Fumarylacetoacetate hydrolase domain-containing protein 2A | |
| Gene Name | FAHD2A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 314 | |
| Subcellular Localization | ||
| Protein Description | May have hydrolase activity.. | |
| Protein Sequence | MLVSGRRRLLTVLLQAQKWPFQPSRDMRLVQFRAPHLVGPHLGLETGNGGGVINLNAFDPTLPKTMTQFLEQGEATLSVARRALAAQLPVLPRSEVTFLAPVTRPDKVVCVGMNYVDHCKEQNVPVPKEPIIFSKFASSIVGPYDEVVLPPQSQEVDWEVELAVVIGKKGKHIKATDAMAHVAGFTVAHDVSARDWQMRRNGKQWLLGKTFDTFCPLGPALVTKDSVADPHNLKICCRVNGEVVQSGNTNQMVFKTEDLIAWVSQFVTFYPGDVILTGTPPGVGVFRKPPVFLKKGDEVQCEIEELGVIINKVV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 94 | Phosphorylation | QLPVLPRSEVTFLAP CCCCCCCCCEEEEEE | 34.18 | 22210691 | |
| 120 | Ubiquitination | MNYVDHCKEQNVPVP CCCCHHHHHCCCCCC | 59.94 | - | |
| 120 | 2-Hydroxyisobutyrylation | MNYVDHCKEQNVPVP CCCCHHHHHCCCCCC | 59.94 | - | |
| 128 | Ubiquitination | EQNVPVPKEPIIFSK HCCCCCCCCCCEEEC | 76.10 | - | |
| 134 | Phosphorylation | PKEPIIFSKFASSIV CCCCCEEECCCHHCC | 19.22 | 24719451 | |
| 174 | Malonylation | GKKGKHIKATDAMAH CCCCCCCEEHHHHHH | 44.98 | 26320211 | |
| 192 | Phosphorylation | FTVAHDVSARDWQMR CEEEEECCHHHHHHH | 24.52 | 22210691 | |
| 203 | Acetylation | WQMRRNGKQWLLGKT HHHHHCCEEEEECCE | 41.68 | 19608861 | |
| 203 | Ubiquitination | WQMRRNGKQWLLGKT HHHHHCCEEEEECCE | 41.68 | 19608861 | |
| 203 | Malonylation | WQMRRNGKQWLLGKT HHHHHCCEEEEECCE | 41.68 | 26320211 | |
| 209 | Ubiquitination | GKQWLLGKTFDTFCP CEEEEECCEECCCCC | 46.09 | - | |
| 213 | Phosphorylation | LLGKTFDTFCPLGPA EECCEECCCCCCCCE | 23.97 | 20068231 | |
| 223 | Phosphorylation | PLGPALVTKDSVADP CCCCEEECCCCCCCC | 29.95 | 20068231 | |
| 224 | Ubiquitination | LGPALVTKDSVADPH CCCEEECCCCCCCCC | 40.29 | - | |
| 234 | Malonylation | VADPHNLKICCRVNG CCCCCCCEEEEEECC | 38.73 | 26320211 | |
| 234 | Ubiquitination | VADPHNLKICCRVNG CCCCCCCEEEEEECC | 38.73 | 19608861 | |
| 234 | Acetylation | VADPHNLKICCRVNG CCCCCCCEEEEEECC | 38.73 | 22642383 | |
| 288 | Ubiquitination | PGVGVFRKPPVFLKK CCCCCCCCCCEECCC | 42.06 | - | |
| 295 | Ubiquitination | KPPVFLKKGDEVQCE CCCEECCCCCEEEEE | 73.98 | - | |
| 312 | Ubiquitination | ELGVIINKVV----- ECEEEEEECC----- | 33.69 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FAH2A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FAH2A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FAH2A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FAH2B_HUMAN | FAHD2B | physical | 26186194 | |
| ODB2_HUMAN | DBT | physical | 26186194 | |
| BOLA3_HUMAN | BOLA3 | physical | 26186194 | |
| FAH2B_HUMAN | FAHD2B | physical | 28514442 | |
| BOLA3_HUMAN | BOLA3 | physical | 28514442 | |
| ODB2_HUMAN | DBT | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...